MBCI
Technology SolarMabCure, Inc.
$0.00
+0.00 +2400.00% today Live
Price History
Not enough data
| Date | Price |
|---|---|
| Oct 7, 2026, live at 9:31 AM ET | 0.00 |
Key Stats
Market Cap
390.544
Avg Volume
19,848
52W High
$0.00
52W Low
$0.00
Div. Yield
0.0%
Valuation
P/B Ratio
0.01
P/S Ratio
0.00
EV/EBITDA
-0.28
EV/Revenue
0.38
Margins
Gross Margin 100.0%
Operating Margin 45.3%
Net Margin 0.0%
EBITDA Margin (135.4%)
Growth & Returns
Return on Equity
(125.1%)
Return on Assets
(4.2%)
Liquidity & Leverage
Current Ratio
0.17
Quick Ratio
0.16
Debt / Equity
0.08
Total Cash
146,436
Total Debt
304,975
About
MabCure, Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure, Inc. in January 2008 to reflect its new business plan. MabCure, Inc. was founded in 2006 and is based in White Plains, New York.